NHS

News

Joy as NICE lifts restrictions on myeloma drug Elrexfio

Patients in England and Wales with multiple myeloma are celebrating a decision by NICE to relax strict restrictions on eligibility to receive Pfizer's Elrexfio.

News

NHS funding boost confirmed ahead of tomorrow's Budget

The UK government has announced a £1.8 billion ($2.3 billion) investment programme that Health Secretary Wes Streeting has said will allow the NHS to deliver an extra 40,000 elective appoin

News

NICE backs two AIs for remote heart failure monitoring

A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can be used by the NHS to monitor heart failure patients with implantable devices, but two others from Biot

News

Lilly's Alzheimer's drug gets UK nod, but no NHS funding

The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to be funded by the NHS, according to cost-effectiveness watchdog NI

News

NICE backs first targeted therapy for ALK+ lung cancer

Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication.

News

NICE turns down Takeda colorectal cancer drug

Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS on the grounds that it is not cost-effective.

Joy as NICE lifts restrictions on myeloma drug Elrexfio

NHS funding boost confirmed ahead of tomorrow's Budget

NICE backs two AIs for remote heart failure monitoring

Lilly's Alzheimer's drug gets UK nod, but no NHS funding

NICE backs first targeted therapy for ALK+ lung cancer

NICE turns down Takeda colorectal cancer drug

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

NHS

Editor's Picks